JPRN-C000000447已完成1 期
A Phase I/II Study of Vinorelbine plus Trastuzumab in Patients with Advanced/Recurrent Breast Cancer Previously Treated with Anthracyclines and Taxanes - A Phase I/II Study of Vinorelbine plus Trastuzumab
Kyushu Breast Cancer Study Group0 个研究点目标入组 60 人开始时间: 2006年7月13日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1.Significant interstitial pneumonia or pulmonary fibrosis by X-ray or CT scan 2.Acute myocardial infarction within 12 months before enrollment 3.Serious cardiac disease which is not controllable by drugs 4.Drug allergy 5.Uncontrolled diabetes or hypertension 6.Persistent use of systemic steroids 7.Uncontrolled medical complications 8.Metastasis to the central nervous system 9.Woman who are apparently or possibly pregnant or have desire to be come pregnant 10.Double cancer 11.Infection or possible infection associated with clinical symptoms such as fever
研究者
相似试验
招募中
2 期
Phase II Study of Vinorelbine + TS-1 in Patients with EGFR-mutated Advanced Non-small Cell Lung CancerJPRN-UMIN000016765Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University37
终止
2 期
Trastuzumab and Vinorelbine in Advanced Breast CancerBreast CancerMetastatic Breast CancerNCT01185509Dana-Farber Cancer Institute31
已完成
2 期
Prospective study of Eribulin plus Trastuzumab in patients with HER-2 positive metastatic breast cancer (KSCOG-BC06)HER2 positive metastatic breast cancerJPRN-UMIN000010761Kurume University School of Medicine Department of Surgery30
已完成
1 期
A phase Ib study of Nivolumab plus Trastuzumab with S-1/Capecitabine plus Oxaliplatin for HER2 positive advanced gastric cancerHER2 positive advanced or unresectable gastric cancerJPRN-UMIN000034222The Cancer Institute Hospital of JFCR45
进行中（未招募）
1 期
A study in HER2-positive breast cancer that has spread to other organs or tissues and has not responded to a course of anti-cancer treatment and a study in HER2-positive inoperable gastric cancer or gastric cancer that has spread to other organs or tissues.HER2-positive metastatic breast cancer and HER2-positive locally advanced or metastatic gastric cancer.MedDRA version: 19.0Level: PTClassification code 10066896Term: HER-2 positive gastric cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0Level: PTClassification code 10065430Term: HER-2 positive breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2012-001547-46-DEF. Hoffmann-La Roche Ltd.160